Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03156608
Other study ID # 1050411
Secondary ID
Status Completed
Phase N/A
First received March 14, 2017
Last updated October 30, 2017
Start date March 6, 2017
Est. completion date June 28, 2017

Study information

Verified date October 2017
Source Intermountain Health Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be conducted on women in labor. Fetal heart rate monitoring will be conducting using the Novii Fetal ECG/EMG system and comparing it to current standard of care external fetal heart rate and tocometry. These approaches will be compared with the respect to need for additional monitoring, amount of nursing intervention, cost and satisfaction of patients and healthcare providers.


Description:

Interpretation of fetal heart rate monitoring during labor is one of the most common procedures performed in the practice of obstetrics. Continuous monitoring of the fetal heart rate is used to identify infants at risk for hypoxic ischemic encephalopathy and allow for intervention to prevent this terrible complication. The quality of the fetal heart rate signal is critical for appropriate interpretation of the characteristics that identify risk.

This is a prospective, randomized pragmatic trial comparing the Novii Fetal ECG/EMG system to external fetal heart rate and tocometry (standard of care) for the amount of time of interpretable fetal heart rate during labor. Randomization will occur in blocks based on BMI to control for the potential effect of BMI.

Fetal heart rate tracings from both groups of women will be reviewed in a blinded fashion by experienced Maternal Fetal Medicine (MFM) physicians who will assess the tracing for quality and interpretability. In addition, both approaches will be compared with respect to the need for additional monitoring modalities, amount of nursing intervention, cost and satisfaction of the patients and healthcare providers.


Recruitment information / eligibility

Status Completed
Enrollment 218
Est. completion date June 28, 2017
Est. primary completion date June 28, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Pregnant women = 18 years of age; gestational age = 37 weeks

- Singleton pregnancy.

- These women will be those presenting to Labor and Delivery for one of the following:

- Rule out labor

- Spontaneous labor

- Induction of labor

Exclusion Criteria:

- Age < 18 years old; multiple gestation pregnancy; gestational age < 37 weeks

- Fetal distress or vaginal bleeding prior to monitor placement

- Previous cesarean section

- Planned cesarean delivery.

- Women who are enrolled in the study but have less than 1 hour of fetal heart rate monitoring after randomization will be excluded from analysis.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Novii ECG/EKG System
External fetal heart rate monitoring
External fetal heart rate monitoring
External fetal heart rate monitoring

Locations

Country Name City State
United States Intermountain Medical Center Murray Utah
United States McKay-Dee Hospital Ogden Utah
United States Utah Valley Hospital Provo Utah
United States LDS Hospital Salt Lake City Utah

Sponsors (2)

Lead Sponsor Collaborator
Intermountain Health Care, Inc. GE Healthcare

Country where clinical trial is conducted

United States, 

References & Publications (5)

Bakker PC, Colenbrander GJ, Verstraeten AA, Van Geijn HP. The quality of intrapartum fetal heart rate monitoring. Eur J Obstet Gynecol Reprod Biol. 2004 Sep 10;116(1):22-7. — View Citation

Cohen WR, Hayes-Gill B. Influence of maternal body mass index on accuracy and reliability of external fetal monitoring techniques. Acta Obstet Gynecol Scand. 2014 Jun;93(6):590-5. doi: 10.1111/aogs.12387. Epub 2014 Apr 30. — View Citation

Cohen WR, Ommani S, Hassan S, Mirza FG, Solomon M, Brown R, Schifrin BS, Himsworth JM, Hayes-Gill BR. Accuracy and reliability of fetal heart rate monitoring using maternal abdominal surface electrodes. Acta Obstet Gynecol Scand. 2012 Nov;91(11):1306-13. doi: 10.1111/j.1600-0412.2012.01533.x. Epub 2012 Oct 19. — View Citation

Dawes GS, Visser GH, Goodman JD, Redman CW. Numerical analysis of the human fetal heart rate: the quality of ultrasound records. Am J Obstet Gynecol. 1981 Sep 1;141(1):43-52. — View Citation

Rooth G, Huch A, Huch R (1987) FIGO news: guidelines for the use of fetal monitoring. Int J Gynaecol Obstet 25:159-167

Outcome

Type Measure Description Time frame Safety issue
Primary Amount of time in minutes with the interpretable fetal heart rate tracing during the course of labor. Quality of the fetal heart rate for each minute of tracing will be assessed visually by 2 or more blinded reviewers. For the purpose of this study, uninterpretable fetal heart rate will be defined as continuous fetal heart rate data with one or more of the following:
Data is missing for more than 75% of the minute of tracing
Artifact is present for more than 25% of the minute of tracing
Missing data or artifact prevents determination of baseline rate
> 15 seconds of continuous missing tracing
Missing data is not continuous but is sufficiently frequent that the one minute segment of tracing could not be used to determine baseline rate
The total number of interpretable minutes of fetal heart tracing and the percentage of time with interpretable fetal heart tracing over the course of labor (Number of minutes with interpretable FHR/Total number of minutes in labor) will be calculated for each patient.
Time of randomization until time of delivery (up to 48 hours)
Secondary Quality and interpretability of the FHT in ten minute segments a. Each 10 minute segment will be deemed to be interpretable if it meets all of the following criteria: i. Sufficient data are available to determine a baseline ii. Sufficient data are available to determine the variability of the tracing iii. Sufficient data are available to identify periodic changes in the tracing (e.g. accelerations, decelerations, etc) b. For each 10 minute segment that is called Uninterpretable, the reviewer will indicate the reason for this designation by selecting one of the following options: i. Poor signal quality due to missing data ii. Poor signal quality due to artifact iii. Adequate signal quality but intrinsic fetal heart rate makes interpretation impossible (e.g. marked variability, etc.) Time of randomization until time of delivery (up to 48 hours)
Secondary Number and quality of uterine contractions in each 10 minute segment: The number of uterine contractions per segment will be recorded b. Signal quality (amount of missing data or artifact) will be recorded Time of randomization until time of delivery (up to 48 hours)
Secondary Number and quality of uterine contractions in each 10 minute segment: Signal quality (amount of missing data or artifact) will be recorded Time of randomization until time of delivery (up to 48 hours)
Secondary Number of times fetal heart rate monitor requires adjusting: Measured by recording the number of times the nurse must adjust the monitoring system to obtain interpretable tracing Time of randomization until time of delivery (up to 48 hours)
Secondary Number of times fetal heart rate monitor requires adjusting: Number of times that hand holding of the monitor is required Time of randomization until time of delivery (up to 48 hours)
Secondary Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode: Need for additional monitoring devices will be determined by the clinical care team including attending physician and/or nurses based on clinical judgment Time of randomization until time of delivery (up to 48 hours)
Secondary Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: Reason 1: Poor signal quality - missing data Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference Time of randomization until time of delivery (up to 48 hours)
Secondary Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference Time of randomization until time of delivery (up to 48 hours)
Secondary Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference Time of randomization until time of delivery (up to 48 hours)
Secondary Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: Reason 4: Patient preference Reason 5: Provider preference Time of randomization until time of delivery (up to 48 hours)
Secondary Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: Reason 5: Provider preference Time of randomization until time of delivery (up to 48 hours)
Secondary Nursing time required for care: We will record the amount of time that the nurses spend at the bedside to adjust the monitor b. Nurses will record the time and reasons that they enter the room Time of randomization until time of delivery (up to 48 hours)
Secondary Nursing time required for care: Nurses will record the time and reasons that they enter the room Time of randomization until time of delivery (up to 48 hours)
Secondary Overall cost of care: Total charge for care from admission to Labor and Delivery to transfer to postpartum care will be recorded for all patients Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Overall cost of care: Delivery type and indication Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Length of labor Length of labor recorded Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Delivery type Type of delivery recorded (e.g., vaginal, cesarean section, etc.) Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Indication for forceps/vacuum extraction or cesarean section, if performed Clinical indication for forceps/vacuum extraction or cesarean section delivery Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Estimated blood loss Amount of blood loss (cc) recorded Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Presence and severity of perineal lacerations Lacerations and degree of laceration recorded Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Intra-amniotic infection (clinical chorioamnionitis or triple I) Infections documented Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Maternal outcomes - Presence of clinical endometritis Endometritis diagnosis recorded Hospitalization for labor, delivery, and recovery - 2-4 days
Secondary Neonatal outcomes - APGAR Scores APGAR scores recorded at 1 minute, 5 minutes, and 10 minutes Hospitalization after delivery - 2-4 days
Secondary Neonatal outcomes - Need for ICU Admission Recorded NICU admission Hospitalization after delivery - 2-4 days
Secondary Neonatal outcomes - Birthweight Infant birthweight (grams) Hospitalization after delivery - 2-4 days
Secondary Neonatal outcomes - Neonatal Sex Neonatal sex recorded Hospitalization after delivery - 2-4 days
Secondary Patient and provider satisfaction - Patient Survey Satisfaction survey completed by patient after delivery of infant Up to 7 days after delivery
Secondary Patient and provider satisfaction - Nurse Survey Satisfaction survey completed by nurse attending labor/delivery after delivery of infant Up to 7 days after delivery
Secondary Patient and provider satisfaction - Attending Physician/Midwife Survey Satisfaction survey completed by physician/midwife attending labor/delivery after delivery of infant Up to 7 days after delivery
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A